CAR-T Cell Therapy
Filter by Publisher
Kalorama

Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)
April 12, 2021
Contract manufacturing is becoming increasingly vital in the pharmaceutical industry, particularly in cell and gene therapy due to the high demand for these innovative products. Kalorama Information’s report, Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs), provides comprehensive insights into this dynamic market.
Report Highlights:
- Biopharmaceutical Contract Manufacturing Market: In-depth analysis of…
$2,400.00 – $3,600.00$4,000.00 – $6,000.00

Cell Therapy and Gene Therapy Markets, 2020
April 27, 2020
What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…
$2,750.00 – $4,125.00$5,500.00 – $8,250.00

CAR-T Cell Therapy Market Review
December 19, 2019
CAR-T Cell Therapy Market Review provides an insightful examination of CAR-T therapy, a revolutionary form of immunotherapy harnessing the body’s T cells to target and eradicate cancer cells. This report delves into the technology behind CAR-T, its application in treating diseases like acute lymphoblastic leukemia, DLBCL B-cell lymphomas, and multiple myeloma.
Key Objectives and Questions…
$2,000.00 – $3,000.00$4,000.00 – $6,000.00

The Worldwide Market for Targeted Cancer Therapeutics
April 11, 2019
Kalorama Information has closely observed the evolution of the cancer treatment market over the past two decades, evaluating the significant impact of new technologies. The Worldwide Market for Targeted Cancer Therapeutics delves into the burgeoning field of targeted therapies, highlighting current products and some of the most promising advancements on the horizon. This report covers…
$1,250.00 – $1,875.00$5,000.00 – $7,500.00